McCurley T L, Greer J P, Glick A D
Department of Pathology, Vanderbilt School of Medicine, Nashville, Tennessee 37232.
Am J Clin Pathol. 1988 Oct;90(4):421-30. doi: 10.1093/ajcp/90.4.421.
The classification of acute leukemia is essential for proper therapy and may be based on morphologic, cytochemical, immunologic, or even ultrastructural studies. Terminal deoxynucleotidyl transferase (TdT) is expressed in most patients with acute lymphocytic leukemia (ALL) and a minority of patients with acute nonlymphocytic leukemia (ANLL). Thirteen patients with ANLL and greater than 30% blasts positive for TdT were studied to establish the clinical, light microscopic, cytochemical, immunologic, and ultrastructural correlates of this phenomenon. Most patients demonstrated some morphologic and cytochemical features of monocytic differentiation. On cytochemical stains, nine had greater than 3% Sudan black-positive blasts. Diffuse alpha naphthyl acetate esterase (ANAE) staining of leukemic cells was present in nine cases, though extremely weak in seven. Blasts in ten patients did not express any other markers of lymphoid differentiation except TdT. However, two patient's immature cells bore CD10 common ALL antigen (CALLA) and CD19 (B4). Ultrastructural studies confirmed nonlymphoid differentiation in all ten patients studied, with a prominent monocytic component present in nine. In no case was a second population of lymphoblasts identified to account for TdT positivity. These patients responded poorly to conventional therapy for ANLL, with complete remissions in 3 of 13 (23%). With conventional therapy for ALL, complete remission was achieved in only two of nine (22%) patients. However, four of seven (57%) patients had a complete remission with high-dose cytosine arabinoside regimens. The authors' studies suggest that patients with TdT-positive ANLL represent a distinct subset that usually displays ultrastructural evidence for monocytic differentiation and is clinically significant in that these patients respond poorly to conventional therapy for both ALL and ANLL. Recognition of the monocytic lineage of these cases by light microscopic examination is difficult because they are often poorly differentiated morphologically and express only weak nonspecific esterase positivity.
急性白血病的分类对于恰当治疗至关重要,其分类可基于形态学、细胞化学、免疫学甚至超微结构研究。末端脱氧核苷酸转移酶(TdT)在大多数急性淋巴细胞白血病(ALL)患者及少数急性非淋巴细胞白血病(ANLL)患者中表达。对13例ANLL且TdT阳性原始细胞大于30%的患者进行了研究,以确定这一现象的临床、光镜、细胞化学、免疫学及超微结构特征。大多数患者表现出单核细胞分化的一些形态学和细胞化学特征。细胞化学染色显示,9例患者苏丹黑阳性原始细胞大于3%。9例患者白血病细胞存在弥漫性α萘乙酸酯酶(ANAE)染色,不过7例极弱。10例患者的原始细胞除TdT外未表达任何其他淋巴细胞分化标志物。然而,2例患者的幼稚细胞带有CD10普通ALL抗原(CALLA)和CD19(B4)。超微结构研究证实,所研究的10例患者均为非淋巴细胞分化,9例存在显著的单核细胞成分。未发现有另一群淋巴母细胞可解释TdT阳性。这些患者对ANLL的传统治疗反应不佳,13例中有3例(23%)完全缓解。采用ALL的传统治疗,9例患者中仅2例(22%)完全缓解。然而,7例患者中有4例(57%)采用大剂量阿糖胞苷方案后完全缓解。作者的研究表明,TdT阳性ANLL患者代表一个独特的亚群,通常显示单核细胞分化的超微结构证据,且具有临床意义,因为这些患者对ALL和ANLL的传统治疗反应均不佳。通过光镜检查识别这些病例的单核细胞系很困难,因为它们形态上往往分化不良,且仅表达微弱的非特异性酯酶阳性。